{"transactions":[{"id":748053,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T20:05:05.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":19676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the first anniversary of the date of grant and immediately prior to the date of the next year's annual meeting of stockholders, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date."}],"balance_after":19676,"derivative":{"exercise_price":29.55,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":19676},"source":{"system":"sec-edgar","filing":"0001193125-26-259519","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526259519/ownership.xml","form_type":"4"}},{"id":784417,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-11T20:30:19.000Z","date":"2026-05-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of March 30, 2026 (the \"Merger Agreement\"), each option to acquire shares of Issuer common stock (the \"Company Stock Options\") that had a per share exercise price equal to or greater than $6.955 per share (\"Cash Amount\") (an \"Out-of-the-Money Option\"), was automatically cancelled and ceased to exist after completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the \"Merger\"), effective as of May 11, 2026, with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent (the \"Effective Time\") , and no consideration was delivered in exchange for such Out-of-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":22.8,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":2600},"source":{"system":"sec-edgar","filing":"0001396943-26-000002","document":"form4-05112026_040507.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1396943/000139694326000002/form4-05112026_040507.xml","form_type":"4"}},{"id":784416,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-11T20:30:19.000Z","date":"2026-05-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of March 30, 2026 (the \"Merger Agreement\"), each option to acquire shares of Issuer common stock (the \"Company Stock Options\") that had a per share exercise price equal to or greater than $6.955 per share (\"Cash Amount\") (an \"Out-of-the-Money Option\"), was automatically cancelled and ceased to exist after completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the \"Merger\"), effective as of May 11, 2026, with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent (the \"Effective Time\") , and no consideration was delivered in exchange for such Out-of-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":22.8,"expiration_date":"2032-05-11","underlying":"Common Stock","underlying_shares":2600},"source":{"system":"sec-edgar","filing":"0001396943-26-000002","document":"form4-05112026_040507.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1396943/000139694326000002/form4-05112026_040507.xml","form_type":"4"}},{"id":784415,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-11T20:30:19.000Z","date":"2026-05-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of March 30, 2026 (the \"Merger Agreement\"), each option to acquire shares of Issuer common stock (the \"Company Stock Options\") that had a per share exercise price equal to or greater than $6.955 per share (\"Cash Amount\") (an \"Out-of-the-Money Option\"), was automatically cancelled and ceased to exist after completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the \"Merger\"), effective as of May 11, 2026, with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent (the \"Effective Time\") , and no consideration was delivered in exchange for such Out-of-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":22.8,"expiration_date":"2031-06-27","underlying":"Common Stock","underlying_shares":2600},"source":{"system":"sec-edgar","filing":"0001396943-26-000002","document":"form4-05112026_040507.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1396943/000139694326000002/form4-05112026_040507.xml","form_type":"4"}},{"id":784414,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-11T20:30:19.000Z","date":"2026-05-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":889,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of March 30, 2026 (the \"Merger Agreement\"), each option to acquire shares of Issuer common stock (the \"Company Stock Options\") that had a per share exercise price equal to or greater than $6.955 per share (\"Cash Amount\") (an \"Out-of-the-Money Option\"), was automatically cancelled and ceased to exist after completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the \"Merger\"), effective as of May 11, 2026, with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent (the \"Effective Time\") , and no consideration was delivered in exchange for such Out-of-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":22.8,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":889},"source":{"system":"sec-edgar","filing":"0001396943-26-000002","document":"form4-05112026_040507.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1396943/000139694326000002/form4-05112026_040507.xml","form_type":"4"}},{"id":784413,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-11T20:30:19.000Z","date":"2026-05-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":889,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of March 30, 2026 (the \"Merger Agreement\"), each option to acquire shares of Issuer common stock (the \"Company Stock Options\") that had a per share exercise price equal to or greater than $6.955 per share (\"Cash Amount\") (an \"Out-of-the-Money Option\"), was automatically cancelled and ceased to exist after completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the \"Merger\"), effective as of May 11, 2026, with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent (the \"Effective Time\") , and no consideration was delivered in exchange for such Out-of-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":22.8,"expiration_date":"2029-06-24","underlying":"Common Stock","underlying_shares":889},"source":{"system":"sec-edgar","filing":"0001396943-26-000002","document":"form4-05112026_040507.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1396943/000139694326000002/form4-05112026_040507.xml","form_type":"4"}},{"id":784412,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-11T20:30:19.000Z","date":"2026-05-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each Company Stock Option that had a per share exercise price less than the Cash Amount (an \"In-the-Money Option\") was automatically cancelled and converted at the Effective Time into the right to receive (A) an amount in cash, without interest, equal to the product obtained by multiplying (x) the excess of the Cash Amount over the exercise price per share underlying such Company Stock Option at the Effective Time by (y) the number of shares underlying such In-the-Money\nOption, subject to the terms and conditions specified in the Merger Agreement and (B) one CVR in respect of each share underlying such In-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":4.46,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001396943-26-000002","document":"form4-05112026_040507.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1396943/000139694326000002/form4-05112026_040507.xml","form_type":"4"}},{"id":784411,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-11T20:30:19.000Z","date":"2026-05-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each Company Stock Option that had a per share exercise price less than the Cash Amount (an \"In-the-Money Option\") was automatically cancelled and converted at the Effective Time into the right to receive (A) an amount in cash, without interest, equal to the product obtained by multiplying (x) the excess of the Cash Amount over the exercise price per share underlying such Company Stock Option at the Effective Time by (y) the number of shares underlying such In-the-Money\nOption, subject to the terms and conditions specified in the Merger Agreement and (B) one CVR in respect of each share underlying such In-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":6.7,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001396943-26-000002","document":"form4-05112026_040507.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1396943/000139694326000002/form4-05112026_040507.xml","form_type":"4"}},{"id":784410,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-11T20:30:19.000Z","date":"2026-05-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of March 30, 2026 (the \"Merger Agreement\"), each option to acquire shares of Issuer common stock (the \"Company Stock Options\") that had a per share exercise price equal to or greater than $6.955 per share (\"Cash Amount\") (an \"Out-of-the-Money Option\"), was automatically cancelled and ceased to exist after completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the \"Merger\"), effective as of May 11, 2026, with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent (the \"Effective Time\") , and no consideration was delivered in exchange for such Out-of-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":26.4,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001396943-26-000002","document":"form4-05112026_040507.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1396943/000139694326000002/form4-05112026_040507.xml","form_type":"4"}},{"id":784409,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-11T20:30:19.000Z","date":"2026-05-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":889,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of March 30, 2026 (the \"Merger Agreement\"), each option to acquire shares of Issuer common stock (the \"Company Stock Options\") that had a per share exercise price equal to or greater than $6.955 per share (\"Cash Amount\") (an \"Out-of-the-Money Option\"), was automatically cancelled and ceased to exist after completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the \"Merger\"), effective as of May 11, 2026, with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent (the \"Effective Time\") , and no consideration was delivered in exchange for such Out-of-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":59.1,"expiration_date":"2028-04-15","underlying":"Common Stock","underlying_shares":889},"source":{"system":"sec-edgar","filing":"0001396943-26-000002","document":"form4-05112026_040507.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396943/000139694326000002/form4-05112026_040507.xml","form_type":"4"}},{"id":784408,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-11T20:30:19.000Z","date":"2026-05-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3742,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of March 30, 2026 (the \"Merger Agreement\"), each option to acquire shares of Issuer common stock (the \"Company Stock Options\") that had a per share exercise price equal to or greater than $6.955 per share (\"Cash Amount\") (an \"Out-of-the-Money Option\"), was automatically cancelled and ceased to exist after completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the \"Merger\"), effective as of May 11, 2026, with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent (the \"Effective Time\") , and no consideration was delivered in exchange for such Out-of-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":23.7,"expiration_date":"2027-10-09","underlying":"Common Stock","underlying_shares":3742},"source":{"system":"sec-edgar","filing":"0001396943-26-000002","document":"form4-05112026_040507.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396943/000139694326000002/form4-05112026_040507.xml","form_type":"4"}},{"id":1103522,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-23T21:00:10.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-hundred percent (100%) of the shares subject to the option shall vest on 6/18/2026, subject to Reporting Person continuing to provide service through such date."}],"balance_after":5000,"derivative":{"exercise_price":4.46,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001415889-25-017967","document":"form4-06232025_050606.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396943/000141588925017967/form4-06232025_050606.xml","form_type":"4"}},{"id":1119718,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T20:05:20.000Z","date":"2025-06-04","kind":"grant","planned":true,"acquired":true,"shares":33662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the first anniversary of the date of grant and immediately prior to the date of the next year's annual meeting of stockholders, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date."}],"balance_after":33662,"derivative":{"exercise_price":17.15,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":33662},"source":{"system":"sec-edgar","filing":"0000950170-25-083050","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025083050/ownership.xml","form_type":"4"}},{"id":1471791,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-21T20:20:16.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-hundred percent (100%) of the shares subject to the option shall vest on 6/20/2025, subject to Reporting Person continuing to provide service through such date."}],"balance_after":50000,"derivative":{"exercise_price":0.67,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-24-017837","document":"form4-06212024_040605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396943/000141588924017837/form4-06212024_040605.xml","form_type":"4"}},{"id":1486915,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T20:45:55.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":23114,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the first anniversary of the date of grant and immediately prior to the date of the next year's annual meeting of stockholders, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date."}],"balance_after":23114,"derivative":{"exercise_price":24.49,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":23114},"source":{"system":"sec-edgar","filing":"0000950170-24-070783","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017024070783/ownership.xml","form_type":"4"}},{"id":1822710,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-26T20:57:59.000Z","date":"2023-07-24","kind":"grant","planned":false,"acquired":true,"shares":26000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 24, 2023, the option originally granted to the Reporting Person was amended to reduce the exercise price to $2.28 per share. All of the other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested and exercisable."}],"balance_after":26000,"derivative":{"exercise_price":2.28,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001209191-23-043425","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1396943/000120919123043425/doc4.xml","form_type":"4"}},{"id":1822709,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-26T20:57:59.000Z","date":"2023-07-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":26000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 24, 2023, the option originally granted to the Reporting Person was amended to reduce the exercise price to $2.28 per share. All of the other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":4.8,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001209191-23-043425","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1396943/000120919123043425/doc4.xml","form_type":"4"}},{"id":1822708,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-26T20:57:59.000Z","date":"2023-07-24","kind":"grant","planned":false,"acquired":true,"shares":26000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 24, 2023, the option originally granted to the Reporting Person was amended to reduce the exercise price to $2.28 per share. All of the other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One thirty-sixth (1/36th) of the shares vested or shall vest on a monthly basis commencing on May 12, 2022, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":26000,"derivative":{"exercise_price":2.28,"expiration_date":"2032-05-11","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001209191-23-043425","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1396943/000120919123043425/doc4.xml","form_type":"4"}},{"id":1822707,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-26T20:57:59.000Z","date":"2023-07-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":26000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 24, 2023, the option originally granted to the Reporting Person was amended to reduce the exercise price to $2.28 per share. All of the other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One thirty-sixth (1/36th) of the shares vested or shall vest on a monthly basis commencing on May 12, 2022, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":0,"derivative":{"exercise_price":5.52,"expiration_date":"2032-05-11","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001209191-23-043425","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1396943/000120919123043425/doc4.xml","form_type":"4"}},{"id":1822706,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-26T20:57:59.000Z","date":"2023-07-24","kind":"grant","planned":false,"acquired":true,"shares":26000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 24, 2023, the option originally granted to the Reporting Person was amended to reduce the exercise price to $2.28 per share. All of the other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested and exercisable."}],"balance_after":26000,"derivative":{"exercise_price":2.28,"expiration_date":"2031-06-27","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001209191-23-043425","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1396943/000120919123043425/doc4.xml","form_type":"4"}},{"id":1822705,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-26T20:57:59.000Z","date":"2023-07-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":26000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 24, 2023, the option originally granted to the Reporting Person was amended to reduce the exercise price to $2.28 per share. All of the other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":5.59,"expiration_date":"2031-06-27","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001209191-23-043425","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1396943/000120919123043425/doc4.xml","form_type":"4"}},{"id":1822704,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-26T20:57:59.000Z","date":"2023-07-24","kind":"grant","planned":false,"acquired":true,"shares":8896,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 24, 2023, the option originally granted to the Reporting Person was amended to reduce the exercise price to $2.28 per share. All of the other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested and exercisable."}],"balance_after":8896,"derivative":{"exercise_price":2.28,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":8896},"source":{"system":"sec-edgar","filing":"0001209191-23-043425","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1396943/000120919123043425/doc4.xml","form_type":"4"}},{"id":1822703,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-26T20:57:59.000Z","date":"2023-07-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8896,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 24, 2023, the option originally granted to the Reporting Person was amended to reduce the exercise price to $2.28 per share. All of the other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":5.6,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":8896},"source":{"system":"sec-edgar","filing":"0001209191-23-043425","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1396943/000120919123043425/doc4.xml","form_type":"4"}},{"id":1822702,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-26T20:57:59.000Z","date":"2023-07-24","kind":"grant","planned":false,"acquired":true,"shares":8896,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 24, 2023, the option originally granted to the Reporting Person was amended to reduce the exercise price to $2.28 per share. All of the other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested and exercisable."}],"balance_after":8896,"derivative":{"exercise_price":2.28,"expiration_date":"2029-06-24","underlying":"Common Stock","underlying_shares":8896},"source":{"system":"sec-edgar","filing":"0001209191-23-043425","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396943/000120919123043425/doc4.xml","form_type":"4"}},{"id":1822701,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-26T20:57:59.000Z","date":"2023-07-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8896,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 24, 2023, the option originally granted to the Reporting Person was amended to reduce the exercise price to $2.28 per share. All of the other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":7.63,"expiration_date":"2029-06-24","underlying":"Common Stock","underlying_shares":8896},"source":{"system":"sec-edgar","filing":"0001209191-23-043425","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396943/000120919123043425/doc4.xml","form_type":"4"}},{"id":1851602,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T20:37:56.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-hundred percent (100%) of the shares subject to the option shall vest on 6/15/2024, subject to Reporting Person continuing to provide service through such date."}],"balance_after":35000,"derivative":{"exercise_price":2.64,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-23-037930","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396943/000120919123037930/doc4.xml","form_type":"4"}},{"id":1862495,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-08T20:56:08.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":16532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the first anniversary of the date of grant and the date of the next year's annual meeting of stockholders, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date."}],"balance_after":16532,"derivative":{"exercise_price":34.33,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":16532},"source":{"system":"sec-edgar","filing":"0000950170-23-027049","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017023027049/ownership.xml","form_type":"4"}},{"id":2167657,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-02T20:05:36.000Z","date":"2022-09-01","kind":"grant","acquired":true,"shares":10391,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the first anniversary of the date of grant, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date."}],"balance_after":10391,"derivative":{"exercise_price":55.58,"expiration_date":"2032-09-01","underlying":"Common Stock","underlying_shares":10391},"source":{"system":"sec-edgar","filing":"0000899243-22-030272","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924322030272/doc4.xml","form_type":"4"}},{"id":2227066,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T22:02:42.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-hundred percent (100%) of the shares subject to the option shall vest on 6/16/2023, subject to Reporting Person continuing to provide service through such date."}],"balance_after":26000,"derivative":{"exercise_price":4.8,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001209191-22-038046","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396943/000120919122038046/doc4.xml","form_type":"4"}},{"id":2271642,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-13T21:04:17.000Z","date":"2022-05-12","kind":"grant","acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One thirty-sixth (1/36th) of the shares shall vest on a monthly basis commencing on May 12, 2022, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":26000,"derivative":{"exercise_price":5.52,"expiration_date":"2032-05-11","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001209191-22-028906","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396943/000120919122028906/doc4.xml","form_type":"4"}},{"id":2421174,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-31T17:37:38.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option shall vest and become exercisable on the Exercisable Date set forth above and 1/48th of the shares subject to the option shall vest monthly thereafter, provided that Reporting Person remains a service provider to the Issuer on each such vest date."}],"balance_after":300000,"derivative":{"exercise_price":8.01,"exercise_date":"2022-03-01","expiration_date":"2032-01-27","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001209191-22-005699","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919122005699/doc4.xml","form_type":"4"}},{"id":2638239,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-08T22:00:40.000Z","date":"2021-07-06","kind":"exercise","acquired":false,"shares":2614,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise reported in this Form 4 was effected pursuant to a 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The option vests as to one third on the first anniversary of the of the vesting commencement date, February 5, 2020, and at a rate of 4.17% each month thereafter until the option is fully vested."}],"balance_after":16561,"derivative":{"exercise_price":17,"expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":2614},"source":{"system":"sec-edgar","filing":"0000899243-21-027902","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321027902/doc4.xml","form_type":"4"}},{"id":2638238,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-08T22:00:40.000Z","date":"2021-07-06","kind":"sale","acquired":false,"shares":100,"price":129.38,"value":12938.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-027902","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321027902/doc4.xml","form_type":"4"}},{"id":2638237,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-08T22:00:40.000Z","date":"2021-07-06","kind":"sale","acquired":false,"shares":100,"price":128.67,"value":12867.0,"ownership":{"direct":true},"balance_after":100,"source":{"system":"sec-edgar","filing":"0000899243-21-027902","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321027902/doc4.xml","form_type":"4"}},{"id":2638236,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-08T22:00:40.000Z","date":"2021-07-06","kind":"sale","acquired":false,"shares":100,"price":126.51,"value":12651.0,"ownership":{"direct":true},"balance_after":200,"source":{"system":"sec-edgar","filing":"0000899243-21-027902","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321027902/doc4.xml","form_type":"4"}},{"id":2638235,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-08T22:00:40.000Z","date":"2021-07-06","kind":"sale","acquired":false,"shares":300,"price":124.31,"value":37293.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The sale price reported is a weighted average price. The Reporting Person undertakes to provide to Beam Therapeutics Inc. (\"BEAM\"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.28 to $124.33, inclusive."}],"balance_after":300,"source":{"system":"sec-edgar","filing":"0000899243-21-027902","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321027902/doc4.xml","form_type":"4"}},{"id":2638234,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-08T22:00:40.000Z","date":"2021-07-06","kind":"sale","acquired":false,"shares":200,"price":123.76,"value":24752.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The sale price reported is a weighted average price. The Reporting Person undertakes to provide to Beam Therapeutics Inc. (\"BEAM\"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.64 to $123.88, inclusive."}],"balance_after":600,"source":{"system":"sec-edgar","filing":"0000899243-21-027902","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321027902/doc4.xml","form_type":"4"}},{"id":2638233,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-08T22:00:40.000Z","date":"2021-07-06","kind":"sale","acquired":false,"shares":100,"price":122.85,"value":12285.0,"ownership":{"direct":true},"balance_after":800,"source":{"system":"sec-edgar","filing":"0000899243-21-027902","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321027902/doc4.xml","form_type":"4"}},{"id":2638232,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-08T22:00:40.000Z","date":"2021-07-06","kind":"sale","acquired":false,"shares":400,"price":121.59,"value":48636.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The sale price reported is a weighted average price. The Reporting Person undertakes to provide to Beam Therapeutics Inc. (\"BEAM\"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.19 to $121.96, inclusive."}],"balance_after":900,"source":{"system":"sec-edgar","filing":"0000899243-21-027902","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321027902/doc4.xml","form_type":"4"}},{"id":2638231,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-08T22:00:40.000Z","date":"2021-07-06","kind":"sale","acquired":false,"shares":200,"price":120.39,"value":24078.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The sale price reported is a weighted average price. The Reporting Person undertakes to provide to Beam Therapeutics Inc. (\"BEAM\"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.37 to $120.40, inclusive."}],"balance_after":1300,"source":{"system":"sec-edgar","filing":"0000899243-21-027902","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321027902/doc4.xml","form_type":"4"}},{"id":2638230,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-08T22:00:40.000Z","date":"2021-07-06","kind":"sale","acquired":false,"shares":100,"price":119.68,"value":11968.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The sale price reported is a weighted average price. The Reporting Person undertakes to provide to Beam Therapeutics Inc. (\"BEAM\"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.67 to $119.68, inclusive."}],"balance_after":1500,"source":{"system":"sec-edgar","filing":"0000899243-21-027902","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321027902/doc4.xml","form_type":"4"}},{"id":2638229,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-08T22:00:40.000Z","date":"2021-07-06","kind":"sale","acquired":false,"shares":200,"price":118.35,"value":23670.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The sale price reported is a weighted average price. The Reporting Person undertakes to provide to Beam Therapeutics Inc. (\"BEAM\"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.00 to $118.71, inclusive."}],"balance_after":1600,"source":{"system":"sec-edgar","filing":"0000899243-21-027902","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321027902/doc4.xml","form_type":"4"}},{"id":2638228,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-08T22:00:40.000Z","date":"2021-07-06","kind":"sale","acquired":false,"shares":200,"price":116.41,"value":23282.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The sale price reported is a weighted average price. The Reporting Person undertakes to provide to Beam Therapeutics Inc. (\"BEAM\"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.13 to $116.69, inclusive."}],"balance_after":1800,"source":{"system":"sec-edgar","filing":"0000899243-21-027902","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321027902/doc4.xml","form_type":"4"}},{"id":2638227,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-08T22:00:40.000Z","date":"2021-07-06","kind":"sale","acquired":false,"shares":614,"price":115.38,"value":70843.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The sale price reported is a weighted average price. The Reporting Person undertakes to provide to Beam Therapeutics Inc. (\"BEAM\"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.04 to $115.88, inclusive."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0000899243-21-027902","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321027902/doc4.xml","form_type":"4"}},{"id":2638226,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-08T22:00:40.000Z","date":"2021-07-06","kind":"exercise","acquired":true,"shares":2614,"price":17,"value":44438.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise reported in this Form 4 was effected pursuant to a 10b5-1 trading plan."}],"balance_after":2614,"source":{"system":"sec-edgar","filing":"0000899243-21-027902","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321027902/doc4.xml","form_type":"4"}},{"id":2649504,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-30T22:46:19.000Z","date":"2021-06-28","kind":"grant","acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-hundred percent (100%) of the shares subject to the option shall vest on 6/28/2022, subject to Reporting Person continuing to provide service through such date."}],"balance_after":26000,"derivative":{"exercise_price":5.59,"expiration_date":"2031-06-27","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001209191-21-044081","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396943/000120919121044081/doc4.xml","form_type":"4"}},{"id":2650248,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-30T22:00:49.000Z","date":"2021-06-28","kind":"exercise","acquired":false,"shares":12045,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise reported in this Form 4 was effected pursuant to a 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vests as to one third on the first anniversary of the of the vesting commencement date, February 5, 2020, and at a rate of 4.17% each month thereafter until the option is fully vested."}],"balance_after":19175,"derivative":{"exercise_price":17,"expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":12045},"source":{"system":"sec-edgar","filing":"0000899243-21-026782","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321026782/doc4.xml","form_type":"4"}},{"id":2650247,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-30T22:00:49.000Z","date":"2021-06-28","kind":"sale","acquired":false,"shares":1000,"price":109.39,"value":109390.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4  were effected pursuant to a Rule 10b5-1 trading plan. Each sale price reported is a weighted average price. The Reporting Person undertakes to provide to Beam Therapeutics Inc. (\"BEAM\"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-026782","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321026782/doc4.xml","form_type":"4"}},{"id":2650246,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-30T22:00:49.000Z","date":"2021-06-28","kind":"sale","acquired":false,"shares":900,"price":108.3,"value":97470.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4  were effected pursuant to a Rule 10b5-1 trading plan. Each sale price reported is a weighted average price. The Reporting Person undertakes to provide to Beam Therapeutics Inc. (\"BEAM\"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.12 to $108.60, inclusive."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0000899243-21-026782","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321026782/doc4.xml","form_type":"4"}},{"id":2650245,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-30T22:00:49.000Z","date":"2021-06-28","kind":"sale","acquired":false,"shares":1162,"price":107.22,"value":124589.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4  were effected pursuant to a Rule 10b5-1 trading plan. Each sale price reported is a weighted average price. The Reporting Person undertakes to provide to Beam Therapeutics Inc. (\"BEAM\"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.00 to $107.60, inclusive."}],"balance_after":1900,"source":{"system":"sec-edgar","filing":"0000899243-21-026782","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321026782/doc4.xml","form_type":"4"}},{"id":2650244,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-30T22:00:49.000Z","date":"2021-06-28","kind":"sale","acquired":false,"shares":3196,"price":106.28,"value":339670.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4  were effected pursuant to a Rule 10b5-1 trading plan. Each sale price reported is a weighted average price. The Reporting Person undertakes to provide to Beam Therapeutics Inc. (\"BEAM\"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.00 to $106.77, inclusive."}],"balance_after":3062,"source":{"system":"sec-edgar","filing":"0000899243-21-026782","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321026782/doc4.xml","form_type":"4"}},{"id":2650243,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-30T22:00:49.000Z","date":"2021-06-28","kind":"sale","acquired":false,"shares":5787,"price":105.37,"value":609776.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4  were effected pursuant to a Rule 10b5-1 trading plan. Each sale price reported is a weighted average price. The Reporting Person undertakes to provide to Beam Therapeutics Inc. (\"BEAM\"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.00 to $105.98, inclusive."}],"balance_after":6258,"source":{"system":"sec-edgar","filing":"0000899243-21-026782","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321026782/doc4.xml","form_type":"4"}},{"id":2650242,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-30T22:00:49.000Z","date":"2021-06-28","kind":"exercise","acquired":true,"shares":12045,"price":17,"value":204765.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise reported in this Form 4 was effected pursuant to a 10b5-1 trading plan."}],"balance_after":12045,"source":{"system":"sec-edgar","filing":"0000899243-21-026782","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321026782/doc4.xml","form_type":"4"}},{"id":2653392,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-28T17:19:50.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the one-year anniversary measured from June 24, 2021 or (ii) the date of the 2022 Annual Meeting of the Issuer's stockholders, assuming continuous service as a Director until such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":4.18,"expiration_date":"2031-06-23","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-21-026236","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000089924321026236/doc4.xml","form_type":"4"}},{"id":2670302,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-14T11:52:44.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":6877,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the first anniversary of the date of grant, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date."}],"balance_after":6877,"derivative":{"exercise_price":87.91,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":6877},"source":{"system":"sec-edgar","filing":"0000899243-21-023464","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321023464/doc4.xml","form_type":"4"}},{"id":2703429,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-20T19:00:39.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":15107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the stock option granted on May 18, 2021 will become vested on the earlier of (i) May 18, 2022 or (ii) the business day prior to the date of the 2022 annual meeting of stockholders."}],"balance_after":15107,"derivative":{"exercise_price":47.01,"expiration_date":"2031-05-18","underlying":"Common Stock","underlying_shares":15107},"source":{"system":"sec-edgar","filing":"0001209191-21-034602","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919121034602/doc4.xml","form_type":"4"}},{"id":2829977,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2021-02-26T23:59:18.000Z","date":"2021-02-10","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Class B Common Stock owned prior to the consummation of the Agreement and Plan of Merger, dated as of October 20, 2020, by and among Panacea Acquisition Corp. (\"Panacea\"), Panacea Merger Subsidiary Corp., a direct, wholly-owned subsidiary of Panacea (\"Merger Sub\"), and Nuvation Bio Inc. (\"Legacy Nuvation\") pursuant to which, as a result of a merger between Legacy Nuvation and Merger Sub, Legacy Nuvation became a direct, wholly-owned subsidiary of Panacea, which subsequently changed its name to Nuvation Bio Inc., was converted into one share of Class A Common Stock; the Class B Common Stock was convertible at any time at the election of the holder (or would have automatically converted at the time of the issuer's initial business combination if not yet converted at such time) with no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Class B Common Stock owned prior to the consummation of the Agreement and Plan of Merger, dated as of October 20, 2020, by and among Panacea Acquisition Corp. (\"Panacea\"), Panacea Merger Subsidiary Corp., a direct, wholly-owned subsidiary of Panacea (\"Merger Sub\"), and Nuvation Bio Inc. (\"Legacy Nuvation\") pursuant to which, as a result of a merger between Legacy Nuvation and Merger Sub, Legacy Nuvation became a direct, wholly-owned subsidiary of Panacea, which subsequently changed its name to Nuvation Bio Inc., was converted into one share of Class A Common Stock; the Class B Common Stock was convertible at any time at the election of the holder (or would have automatically converted at the time of the issuer's initial business combination if not yet converted at such time) with no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Class B Common Stock owned prior to the consummation of the Agreement and Plan of Merger, dated as of October 20, 2020, by and among Panacea Acquisition Corp. (\"Panacea\"), Panacea Merger Subsidiary Corp., a direct, wholly-owned subsidiary of Panacea (\"Merger Sub\"), and Nuvation Bio Inc. (\"Legacy Nuvation\") pursuant to which, as a result of a merger between Legacy Nuvation and Merger Sub, Legacy Nuvation became a direct, wholly-owned subsidiary of Panacea, which subsequently changed its name to Nuvation Bio Inc., was converted into one share of Class A Common Stock; the Class B Common Stock was convertible at any time at the election of the holder (or would have automatically converted at the time of the issuer's initial business combination if not yet converted at such time) with no expiration date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001213900-21-012228","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000121390021012228/ownership.xml","form_type":"4"}},{"id":2829976,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-02-26T23:59:18.000Z","date":"2021-02-10","kind":"exercise","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Class B Common Stock owned prior to the consummation of the Agreement and Plan of Merger, dated as of October 20, 2020, by and among Panacea Acquisition Corp. (\"Panacea\"), Panacea Merger Subsidiary Corp., a direct, wholly-owned subsidiary of Panacea (\"Merger Sub\"), and Nuvation Bio Inc. (\"Legacy Nuvation\") pursuant to which, as a result of a merger between Legacy Nuvation and Merger Sub, Legacy Nuvation became a direct, wholly-owned subsidiary of Panacea, which subsequently changed its name to Nuvation Bio Inc., was converted into one share of Class A Common Stock; the Class B Common Stock was convertible at any time at the election of the holder (or would have automatically converted at the time of the issuer's initial business combination if not yet converted at such time) with no expiration date."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001213900-21-012228","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000121390021012228/ownership.xml","form_type":"4"}},{"id":3098296,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-26T21:26:00.000Z","date":"2020-06-24","kind":"grant","acquired":true,"shares":8896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-hundred percent (100%) of the shares subject to the option shall vest on 6/24/2021, subject to Reporting Person continuing to provide service through such date."}],"balance_after":8896,"derivative":{"exercise_price":5.6,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":8896},"source":{"system":"sec-edgar","filing":"0001209191-20-039131","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396943/000120919120039131/doc4.xml","form_type":"4"}},{"id":3103057,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-22T17:25:00.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the one-year anniversary measured from June 18, 2020 or (ii) the date of the 2021 Annual Meeting of the Issuer's stockholders, assuming continuous service as a Director until such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":9.14,"expiration_date":"2030-06-17","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-20-017388","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000089924320017388/doc4.xml","form_type":"4"}},{"id":3279885,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-11T14:07:14.000Z","date":"2020-02-10","kind":"grant","acquired":true,"shares":31220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to one third on the first anniversary of the of the vesting commencement date, February 5, 2020, and at a rate of 4.17% each month thereafter until the option is fully vested."}],"balance_after":31220,"derivative":{"exercise_price":17,"expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":31220},"source":{"system":"sec-edgar","filing":"0000899243-20-003936","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924320003936/doc4.xml","form_type":"4"}},{"id":3476729,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-27T20:14:14.000Z","date":"2019-06-25","kind":"grant","acquired":true,"shares":8896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-hundred percent (100%) of the shares subject to the option shall vest on 6/25/2020, subject to Reporting Person continuing to provide service through such date."}],"balance_after":8896,"derivative":{"exercise_price":7.63,"expiration_date":"2029-06-24","underlying":"Common Stock","underlying_shares":8896},"source":{"system":"sec-edgar","filing":"0001209191-19-039248","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396943/000120919119039248/doc4.xml","form_type":"4"}},{"id":3480059,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-24T16:11:11.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the one-year anniversary measured from June 20, 2019 or (ii) the date of the 2020 Annual Meeting of the Issuer's stockholders, assuming continuous service as a Non-Employee Director until such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":9,"expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001567619-19-013864","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000156761919013864/doc1.xml","form_type":"4"}},{"id":3568466,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2019-04-02T20:32:44.000Z","date":"2019-03-29","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% shall vest on the first anniversary of the date of grant, March 29, 2020; and the remaining 75% shall vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2023."}],"balance_after":35000,"derivative":{"exercise_price":19.69,"expiration_date":"2029-03-29","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001144204-19-017736","document":"tv517879_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000114420419017736/tv517879_4.xml","form_type":"4"}},{"id":3568465,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-04-02T20:32:44.000Z","date":"2019-03-29","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units. The restricted stock units vest in four equal installments, assuming continuous service on each vesting date, as follows: March 29, 2020; March 29, 2021; March 29, 2022; and March 29, 2023."}],"balance_after":117500,"source":{"system":"sec-edgar","filing":"0001144204-19-017736","document":"tv517879_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000114420419017736/tv517879_4.xml","form_type":"4"}},{"id":3730615,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-12-14T21:30:31.000Z","date":"2018-12-12","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable under a time-based restricted stock unit (\"RSU\") award dated December 12, 2018 that was granted under Assembly Biosciences, Inc.'s 2018 Stock Incentive Plan. Assuming continuous service through each vesting date, 50,000 RSUs vest in the following installments: 20,000 RSUs vest on December 12, 2019 and 10,000 RSUs vest on each of June 12, 2020, December 12, 2020 and June 12, 2021. The remaining 50,000 RSUs vest on June 12, 2021, subject to accelerated vesting upon achievement of certain performance milestones, but in no event will such RSUs vest as a result of such performance milestones prior to December 12, 2019."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001144204-18-064668","document":"tv509183_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000114420418064668/tv509183_form4.xml","form_type":"4"}},{"id":3945564,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-04T18:19:29.000Z","date":"2018-05-02","kind":"grant","acquired":true,"shares":10169,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest in full on the one-year anniversary of May 2, 2018, subject to the Non-Employee Director continuing to serve on the Board through such vesting date."}],"balance_after":10169,"derivative":{"exercise_price":17,"expiration_date":"2028-05-01","underlying":"Common Stock","underlying_shares":10169},"source":{"system":"sec-edgar","filing":"0001140361-18-021810","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000114036118021810/doc1.xml","form_type":"4"}},{"id":4000960,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40947,"kind":"person","name":"COOPER GRAHAM K","position":1,"cik":"0001396943","reported_name":"COOPER GRAHAM K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2018-03-12T11:21:58.000Z","date":"2018-03-08","kind":"grant","acquired":true,"shares":220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest over three years as follows: one-third will vest on the first anniversary of the date of grant, March 8, 2019; and the remaining two-thirds will vest in 24 equal monthly installments, with the options becoming fully vested on March 8, 2021."}],"balance_after":220000,"derivative":{"exercise_price":57.53,"expiration_date":"2028-03-08","underlying":"Common Stock","underlying_shares":220000},"source":{"system":"sec-edgar","filing":"0001144204-18-013973","document":"tv488252_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000114420418013973/tv488252_form4.xml","form_type":"4"}}]}